JPMorgan Chase & Co’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-274,282
Closed -$1.6M 6326
2022
Q4
$1.6M Buy
274,282
+186,915
+214% +$1.09M ﹤0.01% 3099
2022
Q3
$585K Buy
87,367
+41,018
+88% +$275K ﹤0.01% 3654
2022
Q2
$195K Buy
46,349
+46,307
+110,255% +$195K ﹤0.01% 4339
2022
Q1
$0 Hold
42
﹤0.01% 6112
2021
Q4
$0 Sell
42
-2,262
-98% ﹤0.01% 6059
2021
Q3
$8K Sell
2,304
-34,880
-94% -$121K ﹤0.01% 5274
2021
Q2
$157K Sell
37,184
-120,586
-76% -$509K ﹤0.01% 4598
2021
Q1
$787K Buy
157,770
+752
+0.5% +$3.75K ﹤0.01% 3796
2020
Q4
$1.99M Buy
157,018
+48,875
+45% +$618K ﹤0.01% 2969
2020
Q3
$1.04M Sell
108,143
-6,939
-6% -$67K ﹤0.01% 3075
2020
Q2
$1.15M Sell
115,082
-16,635
-13% -$166K ﹤0.01% 2941
2020
Q1
$1.16M Sell
131,717
-36,237
-22% -$320K ﹤0.01% 2880
2019
Q4
$1.55M Buy
167,954
+12,317
+8% +$114K ﹤0.01% 2841
2019
Q3
$915K Buy
155,637
+5,045
+3% +$29.7K ﹤0.01% 3105
2019
Q2
$1.77M Buy
150,592
+2,097
+1% +$24.6K ﹤0.01% 2741
2019
Q1
$1.79M Sell
148,495
-643
-0.4% -$7.76K ﹤0.01% 2701
2018
Q4
$1.87M Sell
149,138
-37,693
-20% -$473K ﹤0.01% 2688
2018
Q3
$2.77M Buy
186,831
+34,920
+23% +$518K ﹤0.01% 2610
2018
Q2
$2.56M Buy
151,911
+5,403
+4% +$90.9K ﹤0.01% 2658
2018
Q1
$3.36M Sell
146,508
-11,558
-7% -$265K ﹤0.01% 2458
2017
Q4
$4.09M Buy
+158,066
New +$4.09M ﹤0.01% 2371
2017
Q3
Sell
-3,099
Closed -$43K 4479
2017
Q2
$43K Sell
3,099
-49,684
-94% -$689K ﹤0.01% 3772
2017
Q1
$900K Buy
52,783
+11,392
+28% +$194K ﹤0.01% 2931
2016
Q4
$426K Buy
41,391
+31,321
+311% +$322K ﹤0.01% 3360
2016
Q3
$102K Buy
+10,070
New +$102K ﹤0.01% 3425
2016
Q1
Sell
-35
Closed -$1K 4324
2015
Q4
$1K Sell
35
-30,000
-100% -$857K ﹤0.01% 4018
2015
Q3
$564K Buy
+30,035
New +$564K ﹤0.01% 2892
2014
Q2
Sell
-227,250
Closed -$3.06M 3541
2014
Q1
$3.06M Buy
+227,250
New +$3.06M ﹤0.01% 2310